{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:47:12Z","timestamp":1792572432431,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.tripleo.2009.11.026","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T04:36:38Z","timestamp":1266208598000},"page":"488-495","source":"Crossref","is-referenced-by-count":126,"title":["Oropharyngeal candidiasis in the era of antiretroviral therapy"],"prefix":"10.1016","volume":"109","author":[{"suffix":"III","given":"George R.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Erlandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer W.","family":"Redding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9102","key":"10.1016\/j.tripleo.2009.11.026_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","article-title":"Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease","volume":"351","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2009.11.026_bib2","first-page":"447","article-title":"Reduction in oropharyngeal candidiasis following introduction of protease inhibitors","volume":"12","author":"Hood","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.tripleo.2009.11.026_bib3","first-page":"2511","article-title":"Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients","volume":"12","author":"Revankar","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.tripleo.2009.11.026_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1601-0825.2003.00990.x","article-title":"Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients","volume":"10","author":"Kerdpon","year":"2004","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM198408093110602","article-title":"Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome","volume":"311","author":"Klein","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.11.026_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/aid.1994.10.925","article-title":"Resistant candidiasis","volume":"10","author":"Powderly","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.tripleo.2009.11.026_bib7","unstructured":"Adult Prevention and Treatment of Opportunistic Infections Guidelines Working Group. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents [draft]. Accessed June 18, 2009."},{"key":"10.1016\/j.tripleo.2009.11.026_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/infdis\/174.4.821","article-title":"Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients","volume":"174","author":"Revankar","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/clinids\/18.2.240","article-title":"Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis","volume":"18","author":"Redding","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib10","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.35.11.2302","article-title":"Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy","volume":"35","author":"Fan-Havard","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1086\/513950","article-title":"Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients","volume":"26","author":"Revankar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/515006","article-title":"Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus\u2013infected patients","volume":"27","author":"Martins","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib13","unstructured":"Erlandsen JEPP, Vallor AC, Kirkpatrick WR, Thompson GR 3rd, Herrera ML, Wickes BL, et al. Current prevalence of Candida spp. colonization, oropharyngeal candidiasis (OPC) and fluconazole (FLU) resistance in HIV\/AIDS patients using combined microbiological and molecular methods of detection. In: Programs and Abstracts of the 48th Annual ICAAC\/IDSA 46th Annual Meeting, Washington, D.C., 2008. Poster M-718."},{"key":"10.1016\/j.tripleo.2009.11.026_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13693780601164306","article-title":"Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient","volume":"45","author":"Westbrook","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/13693780410001731574","article-title":"Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation","volume":"42","author":"Redding","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2003.09.008","article-title":"Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer","volume":"97","author":"Redding","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2009.11.026_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance","volume":"105","author":"Revankar","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2009.11.026_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib19","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/AAC.00473-08","article-title":"Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection","volume":"52","author":"Thompson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/dkl022","article-title":"Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis","volume":"57","author":"Laverdiere","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/714031126","article-title":"Distinct protective host defenses against oral and vaginal candidiasis","volume":"40","author":"Fidel","year":"2002","journal-title":"Med Mycol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1399-302X.1993.tb00580.x","article-title":"Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans","volume":"8","author":"Lacasse","year":"1993","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.65.2.661-667.1997","article-title":"Oral carriage of Candida albicans in murine AIDS","volume":"65","author":"Deslauriers","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.tripleo.2009.11.026_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/340036","article-title":"Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1","volume":"185","author":"de Repentigny","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.qai.0000225011.76439.99","article-title":"Assessment of the association between HIV viral load and CD4 cell count on the occurrence of oropharyngeal candidiasis in HIV-infected patients","volume":"42","author":"Mercante","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tripleo.2009.11.026_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study","volume":"21","author":"Cauda","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tripleo.2009.11.026_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/154407370601900116","article-title":"Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis","volume":"19","author":"Fidel","year":"2006","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.tripleo.2009.11.026_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/088922299309900","article-title":"Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment","volume":"15","author":"Powderly","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.tripleo.2009.11.026_bib29","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/archinte.1994.00420230096011","article-title":"Esophageal candidiasis in patients infected with the human immunodeficiency virus","volume":"154","author":"Rabeneck","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tripleo.2009.11.026_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2036.1994.tb00299.x","article-title":"Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS","volume":"8","author":"Wilcox","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.11.026_bib31","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1053\/gast.1996.v110.pm8964406","article-title":"Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms","volume":"110","author":"Wilcox","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tripleo.2009.11.026_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1086\/592578","article-title":"Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial","volume":"47","author":"Hamza","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib34","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-199610000-00009","article-title":"Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility","volume":"10","author":"Phillips","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.tripleo.2009.11.026_bib35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib36","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1089\/088922299309919","article-title":"Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients","volume":"15","author":"Saag","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.tripleo.2009.11.026_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00002030-200005050-00011","article-title":"Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection","volume":"14","author":"Fichtenbaum","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.tripleo.2009.11.026_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib39","first-page":"2227","article-title":"Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS","volume":"12","author":"Hegener","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.tripleo.2009.11.026_bib40","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/02681219480000511","article-title":"Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole","volume":"32","author":"Dewsnup","year":"1994","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1310\/LF5T-WYY7-0U3E-G8BQ","article-title":"Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study","volume":"1","author":"Vazquez","year":"2000","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.tripleo.2009.11.026_bib45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jac\/dkf206","article-title":"Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient","volume":"50","author":"Bodasing","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib46","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323\/Mycoses Study Group Study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2009.11.026_bib47","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2002"},{"key":"10.1016\/j.tripleo.2009.11.026_bib48","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/JCM.34.9.2154-2157.1996","article-title":"Fluconazole disk diffusion procedure for determining susceptibility of Candida species","volume":"34","author":"Barry","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib49","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/JCM.43.10.5208-5213.2005","article-title":"Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib50","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/JCM.34.7.1794-1797.1996","article-title":"Simple method for detecting fluconazole-resistant yeasts with chromogenic agar","volume":"34","author":"Patterson","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tripleo.2009.11.026_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"Perlin","year":"2007","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.tripleo.2009.11.026_bib53","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.46.6.1704-1713.2002","article-title":"Resistance mechanisms in clinical isolates of Candida albicans","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib54","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.tripleo.2009.11.026_bib55","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryotic cell"},{"key":"10.1016\/j.tripleo.2009.11.026_bib56","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschhauser","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tripleo.2009.11.026_bib57","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1128\/AAC.00740-08","article-title":"Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains","volume":"52","author":"Schubert","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib58","doi-asserted-by":"crossref","first-page":"e1000268","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tripleo.2009.11.026_bib59","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/AAC.48.4.1382-1383.2004","article-title":"Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis","volume":"48","author":"Hernandez","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib60","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2009.11.026_bib61","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/jb.176.18.5686-5696.1994","article-title":"A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase","volume":"176","author":"Douglas","year":"1994","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tripleo.2009.11.026_bib62","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/IAI.64.8.3244-3251.1996","article-title":"Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies","volume":"64","author":"Kurtz","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.tripleo.2009.11.026_bib63","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida spp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409008993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409008993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T19:51:57Z","timestamp":1590609117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210409008993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1079210409008993"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2009.11.026","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}